DUBLIN, Ohio, July 11, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the launch of the Cardinal Health™ One Voice Initiative for pharmacy advocacy, which provides direct financial assistance to state pharmacy associations for the purpose of supporting independent pharmacists' advocacy efforts.  This investment furthers Cardinal Health's longstanding advocacy around the future of independent pharmacies and ongoing partnerships with industry organizations to support pharmacists' efforts to ...

Core Viewpoint - The Invesco Pharmaceuticals ETF (PJP) is a smart beta ETF designed to provide broad exposure to the healthcare sector, specifically focusing on U.S. pharmaceutical companies [1][5][6]. Fund Overview - PJP was launched on June 23, 2005, and has accumulated over $239.95 million in assets, categorizing it as an average-sized ETF within the healthcare sector [1][5]. - The fund aims to match the performance of the Dynamic Pharmaceutical Intellidex Index, which evaluates companies based on various investment merit criteria [5][6]. Cost and Expenses - PJP has an annual operating expense ratio of 0.56%, which is competitive with most peer products in the healthcare ETF space [7]. - The fund offers a 12-month trailing dividend yield of 1.16% [7]. Sector Exposure and Holdings - The ETF is fully allocated to the healthcare sector, with approximately 100% of its portfolio dedicated to this area [8]. - Eli Lilly & Co (LLY) constitutes about 5.41% of the fund's total assets, followed by Amgen Inc (AMGN) and Pfizer Inc (PFE). The top 10 holdings represent approximately 46.64% of total assets [9]. Performance Metrics - As of July 10, 2025, PJP has gained roughly 0.8% year-to-date and approximately 2.82% over the past year [11]. - The fund has traded between $74.59 and $89.61 in the last 52 weeks, with a beta of 0.47 and a standard deviation of 15.71% over the trailing three-year period, indicating a higher risk profile compared to peers [11]. Alternatives - Other ETFs in the pharmaceutical space include iShares U.S. Pharmaceuticals ETF (IHE) and VanEck Pharmaceutical ETF (PPH), which have lower expense ratios of 0.39% and 0.36%, respectively [13]. - Investors seeking lower-risk options may consider traditional market cap weighted ETFs that aim to match healthcare sector returns [13].

WATCH: Trump Floats 200% Tariffs On Pharmaceuticals–Here's What To Know https://t.co/Bc8nEyBz0k ...

We'll be announcing something very soon on pharmaceuticals. Uh we're going to give people about a year, a year and a half to come in and after that they're going to be tariffed. If they have to bring the pharmaceuticals into the country, the drugs and other things into the country, they're going to be tariffed at a very, very high rate, like 200%.We'll give them a certain period of time to get their act together. But they were all here. Now they all left.They went to other places because we allowed people t ...

Market Overview - Markets experienced mixed results with the S&P 500 declining by 0.7%, the Dow Jones Industrial Average down 0.4%, while the Russell 2000 gained 0.7% and the Nasdaq Composite remained flat [2][6] Tariff Announcements - President Trump announced a 50% tariff on copper imports effective August 1st, which led to a 13% increase in copper futures, closing at an all-time high of $5.6450 [3][5] - In addition to copper, Trump is considering tariffs on pharmaceuticals of up to 200% to encourage relocation of supply chains to the U.S. [5] - BRIC nations will face an additional 10% tariff if they align with "anti-American policies," although specifics were not defined [5] Economic Implications - Copper is a critical commodity, widely used in construction and consumer goods, and its price movements are often seen as indicators of economic health, particularly in relation to inflation and recession risks [4] - The Federal Reserve's upcoming decisions on interest rates may be influenced by the recent tariff announcements, as they introduce uncertainty into economic modeling [7] Company Performance - Nvidia shares reached a record high of $160, indicating strength in the tech sector [6] - Conversely, Amazon's shares fell nearly 2% as Prime Days commenced, reflecting some weakness in the retail sector [6] Upcoming Earnings - Delta Airlines is set to report earnings, with strong summer travel expected to be a focal point [9] - Microsoft received an upgrade from Oppenheimer with a price target of $600, although current trading around $500 suggests potential challenges in reaching that target [9]

BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) ("Amneal" or the "Company"), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial results on Tuesday, August 5, 2025, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET. Investor Contact Anthony DiMeo VP, Investor Relations anthony.dimeo@amneal.com About Amneal Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Br ...

Trump Floats 200% Tariffs On Pharmaceuticals https://t.co/6HJGOY7BUK ...

And we'll be announcing something very soon on pharmaceuticals. We're going to give people about a year, a year and a half to come in. And after that, they're going to be tariffed. If they have to bring the pharmaceuticals into the country, the drugs and other things into the country, they're going to be tariffed at a very, very high rate, like 200%.We'll give them a certain period of time to get their act together. But they were all here. Now, they all left.They went to other places because we allowed peop ...

Tariffs - The company is announcing tariffs on pharmaceuticals, chips, and other big items [1] - Tariffs of 50% were imposed on steel and aluminum [1] - Lumber tariffs were recently announced [1] - The company is implementing a 50% tariff on copper [1]

We'll be announcing something very soon on pharmaceuticals. We're going to give people about a year, year and a half to come in. And after that, they're going to be terrified if they have to bring the pharmaceuticals into the country, the drugs and other things into the country. They're going to be terrified at a very, very high rate, like 200%.We'll give them a certain period of time to get their act together. But they were all here now. They all left.They went to other places because we allowed people tha ...